Ivermectin is today's HCQ: someone who wanted to m
Post# of 148155
(Total Views: 408)
Posted On: 03/17/2021 10:52:23 PM
Ivermectin is today's HCQ: someone who wanted to make a splash put it in a petri dish and said "look, it kills covid!".. enough of just about anything will kill covid outside of a living system. pH alone will break it down. And when 85-90% of people recover eventually anyway, it's easy to say "I've seen it work."
Take what we've learned about age bias (older more likely to die) and sex (men more drasticallu effected) and apply here:
It's a very fair and objective analysis of the study. Might it work for LH? Nobody knows; odds seem high the answer is no.
What youtube physicians like Yo and Been, and many real world doctors don't understand about cell and molecular biology could fill volumes. They may have a weak grasp on statistics as well. Some suffer from narcissistic tendencies (I'd say it's even more pronounced than in the general population).
Leronlimab is the only thing that has given undeniable signal of efficacy in severe/critical... that's what the world needs. We need to narrow in and establish that with no doubt, but it's not easy with how differently everyone's disease course is.
On a side note, Vitamin D has shown to have benefit, moreso for women (and possibly of color). It's not Leronlimab though.
Take what we've learned about age bias (older more likely to die) and sex (men more drasticallu effected) and apply here:
Quote:
The placebo group was slightly older (eight people over 65 versus four in the ivermectin group) and had more males (89 vs 78).
Andy Gray, senior lecturer in the Division of Pharmacology at University of KwaZulu-Natal, told GroundUp that it should be noted that the cases were all symptomatic, and the endpoint was the time to those symptoms being reported by patients as resolved.
After 21 days 82% of the patients who received ivermectin had no symptoms and 79% of those who received the placebo were symptom-free. The average time till symptoms alleviated was ten days in the ivermectin group versus 12 in the placebo one. These results are not statistically significant and could also be a result of the placebo group having more participants over 65 and more males. There were also no significant differences in the medical care the two groups needed, or who needed more serious medical intervention.
https://www.dailymaverick.co.za/article/2021-...fence/amp/
It's a very fair and objective analysis of the study. Might it work for LH? Nobody knows; odds seem high the answer is no.
What youtube physicians like Yo and Been, and many real world doctors don't understand about cell and molecular biology could fill volumes. They may have a weak grasp on statistics as well. Some suffer from narcissistic tendencies (I'd say it's even more pronounced than in the general population).
Leronlimab is the only thing that has given undeniable signal of efficacy in severe/critical... that's what the world needs. We need to narrow in and establish that with no doubt, but it's not easy with how differently everyone's disease course is.
On a side note, Vitamin D has shown to have benefit, moreso for women (and possibly of color). It's not Leronlimab though.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼